IRhythm Total Operating Expenses vs Ebit Analysis

IRTC Stock

USD 89.02 6.57 7.97%

IRhythm Technologies financial indicator trend analysis is infinitely more than just investigating iRhythm Technologies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether iRhythm Technologies is a good investment. Please check the relationship between IRhythm Technologies Total Operating Expenses and its Ebit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.

Total Operating Expenses vs Ebit

Total Operating Expenses vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of iRhythm Technologies Total Operating Expenses account and Ebit. At this time, the significance of the direction appears to have pay attention.

The correlation between IRhythm Technologies' Total Operating Expenses and Ebit is -0.97. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Ebit in the same time period over historical financial statements of iRhythm Technologies, assuming nothing else is changed. The correlation between historical values of IRhythm Technologies' Total Operating Expenses and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of iRhythm Technologies are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Total Operating Expenses i.e., IRhythm Technologies' Total Operating Expenses and Ebit go up and down completely randomly.

Correlation Coefficient

-0.97

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Ebit

Most indicators from IRhythm Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into iRhythm Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.At present, IRhythm Technologies' Tax Provision is projected to increase significantly based on the last few years of reporting. Issuance Of Capital Stock is expected to grow at the current pace this year, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.68.

	2021	2022	2023	2024 (projected)
Interest Expense	1.2M	4.1M	3.7M	2.6M
Depreciation And Amortization	16.6M	19.6M	22.1M	23.3M

Interest Expense Depreciation And Amortization

IRhythm Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets
Total Assets		0.96	0.82	0.88	0.97	-0.34	0.96	0.92	0.81	0.56	-0.82	0.85	0.82	0.89	0.67	0.71	0.44	0.94	0.83	-0.28	0.87	0.83	0.82	0.29	0.8	0.88
Short Long Term Debt Total	0.96		0.84	0.88	0.91	-0.34	0.9	0.94	0.8	0.7	-0.83	0.89	0.71	0.91	0.67	0.6	0.53	0.86	0.82	-0.29	0.85	0.84	0.73	0.4	0.8	0.84
Other Current Liab	0.82	0.84		0.98	0.77	-0.42	0.88	0.93	0.84	0.79	-0.99	0.73	0.56	0.95	0.94	0.41	0.57	0.67	0.99	-0.71	0.79	0.81	0.53	0.25	0.94	0.94
Total Current Liabilities	0.88	0.88	0.98		0.83	-0.37	0.92	0.97	0.87	0.72	-0.98	0.8	0.68	0.98	0.92	0.48	0.47	0.75	0.99	-0.65	0.78	0.83	0.6	0.32	0.96	0.98
Total Stockholder Equity	0.97	0.91	0.77	0.83		-0.42	0.97	0.84	0.76	0.48	-0.75	0.8	0.83	0.82	0.59	0.72	0.47	0.97	0.77	-0.23	0.92	0.77	0.84	0.07	0.72	0.82
Other Liab	-0.34	-0.34	-0.42	-0.37	-0.42		-0.44	-0.24	-0.44	-0.17	0.36	-0.3	-0.38	-0.27	-0.28	-0.04	-0.79	-0.38	-0.37	0.21	-0.61	-0.25	-0.02	0.37	-0.3	-0.33
Net Tangible Assets	0.96	0.9	0.88	0.92	0.97	-0.44		0.91	0.78	0.59	-0.86	0.78	0.78	0.9	0.76	0.68	0.5	0.93	0.87	-0.46	0.9	0.78	0.8	0.1	0.82	0.9
Property Plant And Equipment Net	0.92	0.94	0.93	0.97	0.84	-0.24	0.91		0.81	0.74	-0.93	0.86	0.7	0.99	0.85	0.55	0.39	0.79	0.93	-0.56	0.75	0.83	0.68	0.45	0.91	0.94
Current Deferred Revenue	0.81	0.8	0.84	0.87	0.76	-0.44	0.78	0.81		0.49	-0.88	0.81	0.66	0.81	0.73	0.23	0.46	0.62	0.88	-0.36	0.8	0.78	0.39	0.19	0.89	0.87
Net Debt	0.56	0.7	0.79	0.72	0.48	-0.17	0.59	0.74	0.49		-0.74	0.52	0.08	0.77	0.74	0.28	0.59	0.4	0.7	-0.64	0.56	0.65	0.44	0.38	0.65	0.59
Retained Earnings	-0.82	-0.83	-0.99	-0.98	-0.75	0.36	-0.86	-0.93	-0.88	-0.74		-0.72	-0.58	-0.95	-0.95	-0.4	-0.51	-0.65	-0.99	0.7	-0.75	-0.79	-0.51	-0.31	-0.98	-0.97
Accounts Payable	0.85	0.89	0.73	0.8	0.8	-0.3	0.78	0.86	0.81	0.52	-0.72		0.76	0.82	0.53	0.31	0.32	0.74	0.74	-0.19	0.75	0.77	0.55	0.33	0.73	0.75
Cash	0.82	0.71	0.56	0.68	0.83	-0.38	0.78	0.7	0.66	0.08	-0.58	0.76		0.66	0.42	0.58	0.16	0.86	0.62	-0.1	0.64	0.54	0.61	0.17	0.63	0.74
Non Current Assets Total	0.89	0.91	0.95	0.98	0.82	-0.27	0.9	0.99	0.81	0.77	-0.95	0.82	0.66		0.9	0.51	0.43	0.75	0.95	-0.63	0.75	0.8	0.64	0.42	0.93	0.94
Non Currrent Assets Other	0.67	0.67	0.94	0.92	0.59	-0.28	0.76	0.85	0.73	0.74	-0.95	0.53	0.42	0.9		0.36	0.42	0.49	0.94	-0.87	0.59	0.64	0.4	0.32	0.91	0.89
Other Assets	0.71	0.6	0.41	0.48	0.72	-0.04	0.68	0.55	0.23	0.28	-0.4	0.31	0.58	0.51	0.36		0.15	0.81	0.41	-0.11	0.48	0.51	0.89	0.25	0.36	0.53
Long Term Debt	0.44	0.53	0.57	0.47	0.47	-0.79	0.5	0.39	0.46	0.59	-0.51	0.32	0.16	0.43	0.42	0.15		0.4	0.46	-0.29	0.7	0.39	0.2	-0.15	0.42	0.39
Cash And Short Term Investments	0.94	0.86	0.67	0.75	0.97	-0.38	0.93	0.79	0.62	0.4	-0.65	0.74	0.86	0.75	0.49	0.81	0.4		0.67	-0.16	0.82	0.72	0.89	0.13	0.63	0.76
Net Receivables	0.83	0.82	0.99	0.99	0.77	-0.37	0.87	0.93	0.88	0.7	-0.99	0.74	0.62	0.95	0.94	0.41	0.46	0.67		-0.7	0.75	0.8	0.52	0.28	0.97	0.97
Good Will	-0.28	-0.29	-0.71	-0.65	-0.23	0.21	-0.46	-0.56	-0.36	-0.64	0.7	-0.19	-0.1	-0.63	-0.87	-0.11	-0.29	-0.16	-0.7		-0.27	-0.31	-0.12	-0.16	-0.65	-0.61
Common Stock Total Equity	0.87	0.85	0.79	0.78	0.92	-0.61	0.9	0.75	0.8	0.56	-0.75	0.75	0.64	0.75	0.59	0.48	0.7	0.82	0.75	-0.27		0.73	0.65	-0.14	0.68	0.74
Common Stock Shares Outstanding	0.83	0.84	0.81	0.83	0.77	-0.25	0.78	0.83	0.78	0.65	-0.79	0.77	0.54	0.8	0.64	0.51	0.39	0.72	0.8	-0.31	0.73		0.67	0.32	0.76	0.8
Short Term Investments	0.82	0.73	0.53	0.6	0.84	-0.02	0.8	0.68	0.39	0.44	-0.51	0.55	0.61	0.64	0.4	0.89	0.2	0.89	0.52	-0.12	0.65	0.67		0.16	0.48	0.61
Non Current Liabilities Total	0.29	0.4	0.25	0.32	0.07	0.37	0.1	0.45	0.19	0.38	-0.31	0.33	0.17	0.42	0.32	0.25	-0.15	0.13	0.28	-0.16	-0.14	0.32	0.16		0.37	0.32
Inventory	0.8	0.8	0.94	0.96	0.72	-0.3	0.82	0.91	0.89	0.65	-0.98	0.73	0.63	0.93	0.91	0.36	0.42	0.63	0.97	-0.65	0.68	0.76	0.48	0.37		0.97
Other Current Assets	0.88	0.84	0.94	0.98	0.82	-0.33	0.9	0.94	0.87	0.59	-0.97	0.75	0.74	0.94	0.89	0.53	0.39	0.76	0.97	-0.61	0.74	0.8	0.61	0.32	0.97

Click cells to compare fundamentals

IRhythm Technologies Account Relationship Matchups

IRhythm Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	306.2M	511.7M	463.0M	448.2M	433.1M	287.1M
Short Long Term Debt Total	128.6M	122.5M	117.7M	131.0M	129.8M	84.4M
Other Current Liab	32.7M	32.4M	40.3M	50.1M	65.3M	68.6M
Total Current Liabilities	52.1M	65.7M	87.9M	89.1M	107.4M	112.7M
Total Stockholder Equity	135.4M	341.6M	279.5M	239.8M	210.1M	137.6M
Net Tangible Assets	134.5M	340.8M	278.7M	239.0M	274.8M	288.5M
Property Plant And Equipment Net	116.6M	119.0M	140.5M	136.3M	153.4M	161.1M
Current Deferred Revenue	1.3M	930K	3.0M	3.1M	3.3M	1.8M
Net Debt	108.1M	33.8M	(9.9M)	52.2M	93.7M	98.3M
Retained Earnings	(260.4M)	(304.7M)	(406.0M)	(522.2M)	(645.6M)	(613.3M)
Accounts Payable	8.2M	4.4M	10.5M	7.5M	5.5M	5.0M
Cash	20.5M	88.6M	127.6M	78.8M	36.2M	51.2M
Non Current Assets Total	133.4M	133.9M	157.4M	159.5M	202.3M	212.4M
Non Currrent Assets Other	7.9M	14.1M	16.1M	22.3M	45.0M	47.3M
Other Assets	7.9M	98.8M	16.1M	22.3M	25.6M	19.3M
Long Term Debt	33.0M	21.3M	9.7M	34.9M	35.0M	29.7M
Cash And Short Term Investments	140.6M	335.2M	239.1M	213.1M	133.8M	152.1M
Net Receivables	23.9M	29.9M	46.4M	49.9M	61.5M	64.6M
Common Stock Shares Outstanding	25.3M	27.8M	29.3M	29.9M	30.5M	24.7M
Short Term Investments	120.1M	246.6M	111.6M	134.3M	97.6M	106.8M
Liabilities And Stockholders Equity	306.2M	511.7M	463.0M	448.2M	433.1M	287.1M
Non Current Liabilities Total	118.7M	104.5M	95.6M	119.3M	115.7M	96.7M
Inventory	4.0M	5.3M	10.3M	15.2M	14.0M	14.7M
Other Current Assets	4.3M	14.7M	19.4M	21.1M	21.6M	22.7M
Other Stockholder Equity	395.7M	646.3M	685.6M	762.4M	855.8M	898.6M
Total Liab	170.8M	170.1M	183.5M	208.4M	223.0M	149.5M
Property Plant And Equipment Gross	116.6M	119.0M	140.5M	136.3M	203.9M	214.1M
Total Current Assets	172.8M	377.8M	305.5M	288.8M	230.8M	194.6M
Accumulated Other Comprehensive Income	82K	11K	(61K)	(396K)	(112K)	(117.6K)
Property Plant Equipment	116.6M	34.2M	140.5M	75.7M	87.0M	47.6M
Long Term Debt Total	34.9M	33.0M	21.3M	34.9M	31.4M	25.1M
Capital Surpluse	258.0M	395.7M	646.3M	762.4M	876.7M	920.6M
Retained Earnings Total Equity	(203.5M)	(260.4M)	(304.7M)	(522.2M)	(470.0M)	(446.5M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:

How To Invest In IRhythm

Details

Is IRhythm Stock a good investment?

Details

What is IRhythm Technologies' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.85)

Revenue Per Share

18.045

Quarterly Revenue Growth

0.184

Return On Assets

(0.09)

Return On Equity

(1.03)

The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IRhythm Total Operating Expenses vs Ebit Analysis

Total Operating Expenses vs Ebit

Total Operating Expenses vs Ebit Correlation Analysis

Correlation Coefficient

Total Operating Expenses

Ebit

IRhythm Technologies fundamental ratios Correlations

IRhythm Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

IRhythm Technologies fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.99	Other Current Liab
Net Receivables	+ 0.99	Total Current Liabilities
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Total Current Liabilities	+ 0.98	Other Current Liab
Non Current Assets Total	+ 0.98	Total Current Liabilities
Other Current Assets	+ 0.98	Total Current Liabilities

Net Receivables	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Other Current Liab
Inventory	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Total Current Liabilities
Other Current Assets	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.95	Retained Earnings